RxDoctor Payments Data

Kevin Motz, MD

Otolaryngology · Baltimore, MDNPI 1609126077

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,318 of the $5,065 with a category attached, or 65.5%. Inspire Medical Systems, Inc. accounts for 67.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,855, 2.7 times the $691 reported in 2019.

$5,065in general payments, 2019–2025

Across 92 payments — averaging $55.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Janssen Research & Development, LLC$750
  • ZOLL Medical Corporation$508
  • Livanova USA, Inc.$148
  • Integra Lifesciences Corporation$123
  • Johnson & Johnson$114
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Fisher & Paykel Healthcare Limited$900

What the payments were for

  • Consulting fees$1,25825%
  • Travel & lodging$48910%
  • Food & beverage$3,31866%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,065 in reported general payments places this provider in the 85th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$169,464
Medicare patients
316
Services billed
1,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl41$1,297
Gabapentin20$258
Fluticasone Propionate17$216
Omeprazole19$142
Ipratropium Bromide11$100
Famotidine12$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →